Antidepressant medication and ocular factors in association with the need for anti-VEGF retreatment in neovascular age-related macular degeneration.

Irmela MantelMarta ZolaOlivier MirRaphael GaillardFrancine Behar-Cohen

Published in: The British journal of ophthalmology (2018)

This study provides evidence that treatment with antidepressant medication increases the anti-VEGF retreatment requirement in patients with nAMD, possibly through the interplay of antidepressant medication, depression status and VEGF levels.

Keyphrases

age related macular degeneration
vascular endothelial growth factor
major depressive disorder
endothelial cells
adverse drug
healthcare
bipolar disorder
depressive symptoms
physical activity
optical coherence tomography
replacement therapy
smoking cessation
optic nerve